Medicare Part D coverage · albuterol · RxCUI 1437702
albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution
Per the CMS 2026 Part D formulary file, albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution is covered by 5,052 Medicare Part D plans (100% of enrollable products), averaging Tier 1.8, with prior authorization required on 99.7% of covering formularies.
- 100%
- Plan coverage
- 5,052
- Plans covering
- T1.8
- Avg tier
- 99.7%
- Prior auth required
What the CMS Formulary Data Shows for albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution
Per the CMS 2026 Part D formulary file, albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution (RxNorm concept RXCUI 1437702, generic name albuterol) appears on 328 distinct formulary files spanning 5,052 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.8.
Real-world access to albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution depends on utilization management as much as tier placement: 99.7% of covering formularies require prior authorization. 0% require step therapy. 27.4% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,487 Part D beneficiaries filled albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution in 2023, with total plan-and-beneficiary spending of $925,019 and an average per-beneficiary annual cost of $622.07. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution today.
Coverage Details
- Formularies covering
- 328
- Plans covering
- 5,052
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 99.7% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 27.4% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,487
- Total spending
- $925,019
- Avg per beneficiary
- $622.07
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | Yes | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | Yes | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | Yes | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | Yes | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | Yes | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | Yes | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | Yes | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | Yes | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | Yes | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | Unitedhealthcare Insurance Company | T1 | Yes | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | Yes | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | Yes | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | Yes | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | Yes | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | Yes | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | Care Improvement Plus South Central Insurance Co. | T1 | Yes | $0 | VA |
| AARP Medicare Advantage from UHC AL-0001 (HMO-POS) | Unitedhealthcare OF THE Midlands, Inc. | T1 | Yes | $0 | AL |
| AARP Medicare Advantage from UHC CA-0002 (HMO-POS) | UHC OF California | T1 | Yes | $0 | CA |
| UHC Sharp Medicare Advantage CA-001P (HMO-POS) | UHC OF California | T1 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-003P (HMO-POS) | UHC OF California | T1 | Yes | $0 | CA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution covered by Medicare Part D?
Yes, albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution is covered by 5,052 Medicare Part D plans (100% of all Part D formularies).
What tier is albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution on Medicare Part D plans?
albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution averages Tier 1.8 across Part D plans, ranging from Tier 1 to Tier 4.
Does albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution require prior authorization?
99.7% of Part D formularies require prior authorization for albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution. Step therapy: 0%. Quantity limits: 27.4%.
How much does Medicare spend on albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution?
In 2023, total Medicare Part D spending on albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution was $925,019, covering 1,487 beneficiaries. The average spend per beneficiary was $622.07.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule T1.8
- bicalutamide 50 MG Oral Tablet T1.8
- haloperidol 0.5 MG Oral Tablet T1.8
- Atrial Fibrillation sotalol hydrochloride 80 MG Oral Tablet T1.8
- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule [Dilt] T1.8
- metolazone 10 MG Oral Tablet T1.8
Similar prior-authorization rate
- {4 (selinexor 80 MG Oral Tablet [Xpovio]) } Pack [Xpovio 80 MG Once Weekly Carton-80 MG Tablet] 99.7% PA
- mifepristone 300 MG Oral Tablet 99.7% PA
- dornase alfa 1 MG/ML Inhalation Solution [Pulmozyme] 99.7% PA
- sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet [Vosevi] 99.7% PA
- ivacaftor 150 MG Oral Tablet [Kalydeco] 99.7% PA
- deutetrabenazine 12 MG Oral Tablet [Austedo] 99.7% PA